Bovilis IBR marker inac suspension for injection for cattle
Bovilis IBR marker inac suspension for injection for cattle
Authorised
- Bovine herpesvirus 1, strain GK/D gE gene-deleted, Inactivated
Product identification
Medicine name:
Bovilis IBR marker inac suspension for injection for cattle
Active substance:
- Bovine herpesvirus 1, strain GK/D gE gene-deleted, Inactivated
Target species:
-
Cattle
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Bovine herpesvirus 1, strain GK/D gE gene-deleted, Inactivated60.00/enzyme-linked immunosorbent assay unit1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal0day
-
Milk0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AA03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Package description:
- (ID1) 5 Dose: Box with 1 Container (Glass type I) with 5 Dose
- (ID2) 5 Dose: Box with 1 Container (polyethylene terephthalate) with 5 Dose
- (ID3) 50 Dose: Box with 10 Container (Glass type I) each with 5 Dose
- (ID4) 50 Dose: Box with 10 Container (polyethylene terephthalate) each with 5 Dose
- (ID6) 10 Dose: Box with 1 Container (Glass type I) with 10 Dose
- (ID7) 10 Dose: Box with 1 Container (polyethylene terephthalate) with 10 Dose
- (ID8) 100 Dose: Box with 10 Container (Glass type I) each with 10 Dose
- (ID9) 100 Dose: Box with 10 Container (polyethylene terephthalate) each with 10 Dose
- (ID10) 25 Dose: Box with 1 Container (Glass type I) with 25 Dose
- (ID15) 25 Dose: Box with 1 Container (polyethylene terephthalate) with 25 Dose
- (ID17) 250 Dose: Box with 10 Container (Glass type I) each with 25 Dose
- (ID19) 250 Dose: Box with 10 Container (polyethylene terephthalate) each with 25 Dose
- (ID20) 50 Dose: Box with 1 Container (Glass type I) with 50 Dose
- (ID21) 50 Dose: Box with 1 Container (polyethylene terephthalate) with 50 Dose
- (ID22) 500 Dose: Box with 10 Container (Glass type I) each with 50 Dose
- (ID23) 500 Dose: Box with 10 Container (polyethylene terephthalate) each with 50 Dose
- (ID24) 100 Dose: Box with 1 Container (Glass type I) with 100 Dose
- (ID25) 100 Dose: Box with 1 Container (polyethylene terephthalate) with 100 Dose
- (ID26) 1000 Dose: Box with 10 Container (Glass type I) each with 100 Dose
- (ID27) 1000 Dose: Box with 10 Container (polyethylene terephthalate) each with 100 Dose
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 97/018/06-C
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0237/001
Concerned member states:
-
Belgium
-
Czechia
-
Estonia
-
France
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 16/09/2025
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
Combined File of all Documents
English (PDF)
Download Published on: 10/04/2026